1-3 of 3
Mark J. Smyth
Close
Sort by
Journal Articles

Human peripheral blood DNAM-1 neg NK cells are a terminally differentiated subset with limited effector functions

Kimberley A. Stannard, Sébastien Lemoine, Nigel J. Waterhouse, Frank Vari, Lucienne Chatenoud, Maher K. Gandhi, Ludovic Martinet, Mark J. Smyth, Camille Guillerey
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1681–1694.
https://doi.org/10.1182/bloodadvances.2018030676
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy

Sara Mastaglio, Eric Wong, Travis Perera, Jane Ripley, Piers Blombery, Mark J. Smyth, Rachel Koldej, David Ritchie
Journal: Blood Advances
Blood Adv (2018) 2 (4): 335–346.
https://doi.org/10.1182/bloodadvances.2017015230
Published: 2018
Includes: Supplemental data
Journal Articles

Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT

Kate H. Gartlan, Antiopi Varelias, Motoko Koyama, Renee J. Robb, Kate A. Markey, Karshing Chang, Andrew N. Wilkinson, David Smith, Md Ashik Ullah, Rachel D. Kuns, Neil C. Raffelt, Stuart D. Olver, Katie E. Lineburg, Bianca E. Teal, Melody Cheong, Michele W. L. Teng, Mark J. Smyth, Siok-Keen Tey, Kelli P. A. MacDonald, Geoffrey R. Hill
Journal: Blood Advances
Blood Adv (2017) 1 (6): 341–351.
https://doi.org/10.1182/bloodadvances.2016002980
Published: 2017